Trends in Medicaid spending on inhalers in the United States, 2012-2018.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2021.27.12.1744
Abstract: BACKGROUND: Chronic obstructive pulmonary disease (COPD) and asthma are common respiratory diseases that impose a significant economic burden on Medicaid. Inhalers are the mainstay treatment for relieving symptoms and improving outcomes for COPD and asthma… read more here.
Keywords: trends medicaid; 2012 2018; spending; medicaid spending ... See more keywords